Towards a Precision Medicine Approach and In Situ Vaccination against Prostate Cancer by PSMA-Retargeted oHSV

Prostate specific membrane antigen (PSMA) is a specific high frequency cell surface marker of prostate cancers. Theranostic approaches targeting PSMA show no major adverse effects and rule out off-tumor toxicity. A PSMA-retargeted oHSV (R-405) was generated which both infected and was cytotoxic excl...

Descripción completa

Detalles Bibliográficos
Autores principales: Vannini, Andrea, Parenti, Federico, Bressanin, Daniela, Barboni, Catia, Zaghini, Anna, Campadelli-Fiume, Gabriella, Gianni, Tatiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541339/
https://www.ncbi.nlm.nih.gov/pubmed/34696515
http://dx.doi.org/10.3390/v13102085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541339/
https://www.ncbi.nlm.nih.gov/pubmed/34696515
http://dx.doi.org/10.3390/v13102085

Ejemplares similares